A pH reversibly activatable NIR photothermal/photodynamic-in-one agent integrated with renewable nanoimplants for image-guided precision phototherapy

Xu Zhao,Kai-Chao Zhao,Li-Jian Chen,Yu-Shi Liu,Jia-Lin Liu,Xiu-Ping Yan
DOI: https://doi.org/10.1039/d0sc04408c
IF: 8.4
2021-01-01
Chemical Science
Abstract:A smart NIR photothermal/photodynamic-in-one agent integrated with renewable nanoimplants for autofluorescence- and continuous external irradiation-free image-guided precision tumor-targeting phototherapy.
chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper aims to address several key issues in the field of phototherapy: 1. **Tumor Specificity**: Existing phototherapy strategies often lack tumor specificity, leading to asynchronous treatment and overlapping side effects. 2. **Thermal Damage Issue**: Due to the need for continuous external irradiation, severe thermal damage is inevitably caused. 3. **Synergistic Effect of Photothermal Therapy (PTT) and Photodynamic Therapy (PDT)**: Although many studies have attempted to integrate PTT and PDT into one platform to enhance therapeutic effects, most multi-component-based PTT and PDT agents result in asynchronous treatment and overlapping side effects. 4. **Need for Continuous External Irradiation**: Traditional phototherapeutic agents are mostly in an "always-on" state, lacking tumor specificity, leading to non-specific damage to normal tissues. To address these issues, researchers have designed an acid-activated photothermal and photodynamic synchronous diagnostic and therapeutic nano-platform that does not require continuous external irradiation for precise tumor-targeted near-infrared (NIR) imaging-guided therapy. This platform utilizes pH-reversible responsive asymmetric cyanine bromide as a tumor-specific NIR PTT/PDT integrated agent and employs ultra-small NIR persistent luminescence nanoparticles as imaging units and renewable nano-implants, thereby achieving precise tumor targeting and efficient treatment while reducing side effects. Additionally, by introducing biotin-functionalized polyethylene glycol (PEGBT), the platform is endowed with active tumor targeting capability and extended blood circulation time.